Vomiting
📧 Sign up to get email alerts when something new happens for Vomiting.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2022-04-08EMA Withdrawn: Palonosetron Hospira (palonosetron hydrochloride) — Pfizer Europe MA EEIG
Palonosetron Hospira (palonosetron hydrochloride) has been withdrawn in the EMA system.
-
EMA withdrawal · 2021-03-19EMA Application withdrawn: Dexamethasone Taw (Dexamethasone (sodium phosphate)) — Taw Pharma (Ireland) Ltd
EMA withdrew the application for Dexamethasone Taw (dexamethasone sodium phosphate) by Taw Pharma (Ireland) Ltd.
-
EMA withdrawal · 2020-03-02EMA Withdrawn: Varuby (rolapitant) — TESARO Bio Netherlands B.V.
EMA has withdrawn Varuby (rolapitant) from the market in the Netherlands/EMA record; the withdrawal concerns vomiting, nausea, and cancer in…
-
CLINICAL_TRIALS withdrawal · 2016-03-17Clinical Trial Update: Evidence of Haloperidol Absorption After Topical Administration [EARLY_Phase 1]
An early Phase 1 trial evaluating the absorption of topical haloperidol for nausea and vomiting has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-09-13Clinical Trial Update: Domperidone for Relief of Gastrointestinal Disorders [NA]
The clinical trial evaluating domperidone for relief of various gastrointestinal disorders has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2009-10-13EMA Application withdrawn: Zunrisa (casopitant) — Glaxo Group Ltd
The EMA withdrew the application for Zunrisa (casopitant) from Glaxo Group Ltd for indications in vomiting, postoperative nausea and vomitin…